Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
SAGE Open Medical Case Reports|March 10, 2023
Primary thromboprophylaxis in not surgically treated intra-luminal gastrointestinal cancer (ILGC) treated with first-line chemotherapy: A single institution preliminary safety reportFelice V Vitale, Valentina Giaimo, Alessandro D'Angelo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 23, 2025
Beyond germ cell tumors: focus on Leydig cell neoplasms from a single-center experienceRosario Leonardi, Alessandro D'Angelo, Guglielmo Mantica, et al.
Critical Reviews in Oncology/Hematology|September 28, 2011
Early detection, prevention and management of cutaneous adverse events due to sorafenib: recommendations from the Sorafenib Working GroupSergio Bracarda, Enzo Maria Ruggeri, Marcello Monti, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 14, 2011
Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series studyFelice Vito Vitale, Stefano Rotondo, Edoardo Sessa, et al.
Oncotargets and Therapy|June 28, 2014
Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapiesMichele La Greca, Giuseppe Grasso, Giovanna Antonelli, et al.
Oncology Letters|February 13, 2016
Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancerGiovanna Antonelli, Massimo Libra, Vincenzo Panebianco, et al.
Clinics in Sports Medicine|November 24, 2018
Adipose-Derived Stem Cell Treatments and FormulationsBerardo Di Matteo, Mohamed Marzouk El Araby, Alessandro D'Angelo, et al.
Future Oncology (London, England)|October 6, 2015
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patientsVincenza Conteduca, Orazio Caffo, Lucia Fratino, et al.
Clinical Genitourinary Cancer|September 19, 2015
Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient ProgrammeFrancesca Maines, Orazio Caffo, Ugo De Giorgi, et al.
BJU International|July 4, 2014
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient ProgrammeOrazio Caffo, Ugo De Giorgi, Lucia Fratino, et al.
Pageof 2